Auxly Enterprise Value Over E B I T D A from 2010 to 2024

XLY Stock  CAD 0.04  0  7.14%   
Auxly Cannabis Enterprise Value Over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value Over EBITDA is likely to grow to -13.46 this year. During the period from 2010 to 2024, Auxly Cannabis Enterprise Value Over EBITDA quarterly data regression pattern had sample variance of 2.7 M and median of (4.63). View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(14.17)
Current Value
(13.46)
Quarterly Volatility
1.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Auxly Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Auxly Cannabis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.8 M, Interest Expense of 26.9 M or Total Revenue of 106.1 M, as well as many indicators such as Price To Sales Ratio of 0.0931, Dividend Yield of 0.0 or PTB Ratio of 0.18. Auxly financial statements analysis is a perfect complement when working with Auxly Cannabis Valuation or Volatility modules.
  
This module can also supplement various Auxly Cannabis Technical models . Check out the analysis of Auxly Cannabis Correlation against competitors.

Other Information on Investing in Auxly Stock

Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.